UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy

Clinical Microbiology Reviews, 2005-01, Vol.18 (1), p.217-245

2005

Volltextzugriff (PDF)

COPD management in primary care: an observational, community pharmacy-based study

The Annals of pharmacotherapy, 2010-02, Vol.44 (2), p.257

2010

Volltextzugriff (PDF)

Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8

Reviews in medical virology, 2001-11, Vol.11 (6), p.381-395

2001

Volltextzugriff (PDF)

Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423

Biochemical pharmacology, 2004-01, Vol.67 (2), p.325-336

2004

Volltextzugriff (PDF)

Self-medication of upper gastrointestinal symptoms: a community pharmacy study

The Annals of pharmacotherapy, 2009-05, Vol.43 (5), p.890

2009

Volltextzugriff (PDF)

Drug–drug interactions with direct oral anticoagulants: development of a consensus list for ambulatory care

International journal of clinical pharmacy, 2023-04, Vol.45 (2), p.364-374

2023

Volltextzugriff (PDF)

Role of the Human Herpesvirus 6 U69-Encoded Kinase in the Phosphorylation of Ganciclovir

Molecular pharmacology, 2002-09, Vol.62 (3), p.714-721

2002

Volltextzugriff (PDF)

Productive Infection of Primary Macrophages with Human Herpesvirus 7

Journal of Virology, 2001-11, Vol.75 (21), p.10511-10514

2001

Volltextzugriff (PDF)

Characterisation of patient encounters in community pharmacies (with special focus on self-medication)

The International journal of pharmacy practice, 2015-06, Vol.23 (3), p.228-231

2015

Volltextzugriff (PDF)

Therapeutic Approaches to HHV-6 Infection

Perspectives in Medical Virology, 2006, Vol.12, p.291-301

2006

Volltextzugriff (PDF)

Human herpesvirus 6 infection arrests cord blood mononuclear cells in G2 phase of the cell cycle

FEBS letters, 2004-02, Vol.560 (1-3), p.25-29

2004

Volltextzugriff (PDF)

Modulation of the cytokine network in human adult astrocytes by human herpesvirus-6A

Journal of neuroimmunology, 2005-07, Vol.164 (1), p.37-47

2005

Volltextzugriff (PDF)

Human herpesvirus 6 infection arrests cord blood mononuclear cells in G(2) phase of the cell cycle

FEBS letters, 2004-02, Vol.560 (1-3), p.25-29

2004

Volltextzugriff (PDF)

Human herpesvirus 6 infection arrests cord blood mononuclear cells in G sub(2) phase of the cell cycle

FEBS letters, 2004-02, Vol.560 (1-3), p.25-29

2004

Volltextzugriff (PDF)

Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses

Antiviral research, 2006-10, Vol.72 (1), p.60-67

2006

Volltextzugriff (PDF)

Prevalence of alcohol-drug interactions in community-dwelling older patients with polypharmacy

Drug metabolism and personalized therapy, 2021-06, Vol.36 (4), p.281

2021

Volltextzugriff (PDF)

Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A961V mutation in HHV-6 ganciclovir resistance

Antiviral research, 2004, Vol.64 (1), p.17-25

2004

Volltextzugriff (PDF)

Human herpesvirus 6 infection arrests cord blood mononuclear cells in G 2 phase of the cell cycle

FEBS letters, 2004-02, Vol.560 (1), p.25-29

2004

Volltextzugriff (PDF)

Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A961V mutation in HHV-6 ganciclovir resistance

Antiviral research, 2004-10, Vol.64 (1), p.17

2004

Volltextzugriff (PDF)

Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A 961V mutation in HHV-6 ganciclovir resistance

Antiviral research, 2004, Vol.64 (1), p.17-25

2004

Volltextzugriff (PDF)

Anti-herpesvirus activity of (1′ S,2′ R)-9-[[1′,2′-bis(hydroxymethyl)-cycloprop-1′-yl]methyl]guanine (A-5021) in vitro and in vivo

Antiviral research, 2001-02, Vol.49 (2), p.115-120

2001

Volltextzugriff (PDF)

Medication use and disease management of type 2 diabetic flemish patients

Pharmacy world and science, 2008, Vol.30 (1), p.51-56

2008

Volltextzugriff (PDF)

Anti-herpesvirus activity of (1'S, 2'R)-9[[1', 2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl] x guanine (A-5021) in vitro and in vivo

Antiviral research, 2001-02, Vol.49 (2), p.115-120

2001

Volltextzugriff (PDF)

Medication use and disease management of type 2 diabetes in Belgium

Pharmacy world and science, 2008-01, Vol.30 (1), p.51-56

2008

Volltextzugriff (PDF)

Large-Scale Experiments to Improve Monopile Scour Protection Design Adapted to Climate Change—The PROTEUS Project

Energies (Basel), 2019-05, Vol.12 (9), p.1709

2019

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(25)
Buchkapitel
(1)

Sprache

Englisch
(26)
Japanisch
(5)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy

COPD management in primary care: an observational, community pharmacy-based study

Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8

Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423

Self-medication of upper gastrointestinal symptoms: a community pharmacy study

Drug–drug interactions with direct oral anticoagulants: development of a consensus list for ambulatory care

Role of the Human Herpesvirus 6 U69-Encoded Kinase in the Phosphorylation of Ganciclovir

Productive Infection of Primary Macrophages with Human Herpesvirus 7

Characterisation of patient encounters in community pharmacies (with special focus on self-medication)

Therapeutic Approaches to HHV-6 Infection

Human herpesvirus 6 infection arrests cord blood mononuclear cells in G2 phase of the cell cycle

Modulation of the cytokine network in human adult astrocytes by human herpesvirus-6A

Human herpesvirus 6 infection arrests cord blood mononuclear cells in G(2) phase of the cell cycle

Human herpesvirus 6 infection arrests cord blood mononuclear cells in G sub(2) phase of the cell cycle

Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses

Prevalence of alcohol-drug interactions in community-dwelling older patients with polypharmacy

Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A961V mutation in HHV-6 ganciclovir resistance

Human herpesvirus 6 infection arrests cord blood mononuclear cells in G 2 phase of the cell cycle

Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A961V mutation in HHV-6 ganciclovir resistance

Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A 961V mutation in HHV-6 ganciclovir resistance

Anti-herpesvirus activity of (1′ S,2′ R)-9-[[1′,2′-bis(hydroxymethyl)-cycloprop-1′-yl]methyl]guanine (A-5021) in vitro and in vivo

Medication use and disease management of type 2 diabetic flemish patients

Anti-herpesvirus activity of (1'S, 2'R)-9[[1', 2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl] x guanine (A-5021) in vitro and in vivo

Medication use and disease management of type 2 diabetes in Belgium

Large-Scale Experiments to Improve Monopile Scour Protection Design Adapted to Climate Change—The PROTEUS Project

Suchergebnisse filtern